Campaign for RU486 & Contraceptive Research

7/14/98 -- NEW REPORT SHOWS AMERICAN WOMEN ENTHUSIASTIC ABOUT MIFEPRISTONE USE: Extremist Attempt to Block FDA Approval is Medical McCarthyism, Says Feminist Majority

4/29/98 -- EVIDENCE FOR SAFETY AND EFFICACY OF MIFEPRISTONE MOUNTS

Feminist Majority Foundation Applauds Transfer of Mifepristone (RU 486) Patent Rights To Dr. Edouard Sakiz, Former Roussel Uclaf CEO; Anti-Abortion Boycott Backfires -- April 8, 1997

Statement of Eleanor Smeal, Feminist Majority Foundation President, on FDA Hearings Concerning the Approval of Mifepristone
This Feminist Majority Foundation news release was distributed at the July 19, 1996 FDA hearings before the Reproductive Health Drugs Advisory Committee.

Testimony Before the U.S. Food and Drug Administration Advisory Committee on Reproductive Health: July 19, 1996
Feminist Majority Foundation president Eleanor Smeal's testimony about why the legal distribution of mifepristone would be beneficial to the health of U.S. women.

Repro Rights Home | RU 486 & Contraceptive Research | National Clinic Access Project | Rock for Choice
Choices Campus Community | Abortion Rights | Birth Control | Other Repro Health | Global Repro Rights